What innovations are being explored in cannabinoid formulations to enhance bioavailability?
What innovations are being explored in cannabinoid formulations to enhance bioavailability? Innovations in cannabinoid formulations aimed at enhancing bioavailability include the development of nanoemulsions, liposomal formulations, and enhanced extraction methods. These advanced delivery systems can improve the absorption of cannabinoids in the body, ensuring that more active compounds reach systemic circulation. For example, nanoemulsions use tiny lipid particles to increase the solubility of cannabinoids, facilitating their absorption through biological membranes. Liposomal formulations encase cannabinoids in lipid spheres, enhancing their stability and bioavailability. By leveraging these innovations, researchers and manufacturers can optimize cannabinoid formulations for better therapeutic outcomes (Wilkinson et al., 2020).